血管生成抑制蛋白在肾脏病领域的研究进展

    Research advances of vasohibin family regulating angiogenesis in kidney diseases

    • 摘要: 肾脏微血管的血管内皮损伤及肾小管管周毛细血管的减少是急慢性肾脏病的发病及肾脏修复机制中非常重要的环节。血管生成抑制蛋白(vasohibin,VASH)被认为是目前唯一被发现具有内皮源性调节血管生成的调节因子,在急性肾损伤、慢性肾脏病、糖尿病肾病和肾脏肿瘤等疾病中扮演着重要的角色。多数研究认为VASH有望成为相关肾脏疾病诊断和治疗的分子标志物以及分子靶向治疗的有效蛋白因子。因此,本文主要对VASH家族成员的结构特点、生物学活性及其在肾脏病领域的相关研究做一综述。

       

      Abstract: Vascular endothelial injury of renal microvessels and a decrease of peritubular capillaries are vital in the pathogenesis of acute and chronic renal disease. Capable of endodermal regulation of angiogenesis,vasohibin family(VASH)plays an important role in such diseases as acute kidney injury,chronic kidney disease,diabetic nephropathy and renal tumor. Many studies have suggested that VASH is expected to be a molecular marker for diagnosing and treating kidney diseases and it will become an effective protein factor for molecular targeted therapy. This review summarized structural characteristics,biological activities and related studies of vasohibin family members in kidney diseases.

       

    /

    返回文章
    返回